These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5988859)

  • 21. [INVESTIGATIONS ON EXPENDITURES FOR DRUGS. SOME RESULTS OF RESEARCH IN THE DISTRICT INSTITUTE OF NATIONAL HEALTH IN RYCHNOV NAD KN E ZNOU IN MARCH AND APRIL 1963].
    OMELCUK A; STACH J
    Cesk Zdrav; 1964 Aug; 12():370-8. PubMed ID: 14194289
    [No Abstract]   [Full Text] [Related]  

  • 22. [Analysis of drug and other expenditures].
    Tamura M; Kamitani N; Shimakawa K; Shimono T
    Iryo; 1971 Sep; 25(9):691-3. PubMed ID: 5126622
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse drug reactions: a review for healthcare practitioners.
    Young LR; Wurtzbacher JD; Blankenship CS
    Am J Manag Care; 1997 Dec; 3(12):1884-906; quiz 1909-10. PubMed ID: 10178476
    [No Abstract]   [Full Text] [Related]  

  • 24. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors influencing hospital expenditures and causes of differences between various regions in Czechoslovakia].
    Fikr V
    Cesk Zdrav; 1980 Apr; 28(4):162-4. PubMed ID: 7371112
    [No Abstract]   [Full Text] [Related]  

  • 26. THE ECONOMICS OF ADVERSE DRUG REACTIONS--case studies.
    Visconti JA; Smith MC
    Ann Pharmacother; 2006 Mar; 40(3):529-36. PubMed ID: 16507611
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: "Normal laboratory values".
    Kiyogi SK
    N Engl J Med; 1974 Aug; 291(7):367. PubMed ID: 4852664
    [No Abstract]   [Full Text] [Related]  

  • 28. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
    Seshamani M; Gray A
    Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice expenses.
    Weiss GG
    Med Econ; 2003 Nov; 80(21):31-2, 35-7. PubMed ID: 14666866
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in patterns of medication as function of age of the aging patient (review of the literature)].
    Rosario Burgos EN
    Bol Asoc Med P R; 1995; 87(7-9):121-3. PubMed ID: 8703264
    [No Abstract]   [Full Text] [Related]  

  • 34. The economic impact of high-technology home care.
    Arno PS; Bonuck KA; Padgug R
    Hastings Cent Rep; 1994; 24(5):S15-9. PubMed ID: 8002295
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacoeconomics of subcutaneous allergen immunotherapy.
    Incorvaia C; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Ciprandi G; D'Anneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():17-20. PubMed ID: 18924462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economics of age-group swimming in Ontario.
    Eynon RB; Kitchen PD; Semotiuk DM
    Can J Appl Sport Sci; 1980 Sep; 5(3):132-6. PubMed ID: 7449023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Approximation to the cost of pharmacological treatment of rheumatoid arthritis in Spain].
    Mera Varela A; Blanco Rodríguez J; Caamaño Freire M
    An Med Interna; 2003 Mar; 20(3):114-21. PubMed ID: 12756895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nobody likes to pay the cost.
    WERBLE W
    Ohio State Med J; 1959 Feb; 55(2):220-4. PubMed ID: 13633176
    [No Abstract]   [Full Text] [Related]  

  • 39. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Material interest in the economic utilization of resources and its consequence for the internal economics of institutes of national health].
    Smolek IA
    Cesk Zdrav; 1966 Dec; 14(12):622-9. PubMed ID: 5977862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.